Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Anders Rabbe, CEO, Isofol Medical AB (publ)
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Isofol Medical at Pareto Securities' Health Care Conference
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Keith Henderson, President & CEO And Director of Velocity Minerals Ltd., emphasizes the importance of excellent management and provides investors with direct access to vetted companies at the Metals Investor Forum in Vancouver.|Keith Henderson, President
00:10:00
3S KOREA company introduction | Jong-Ik Park, CEO, 3S Korea Co Ltd6031K:KOE
00:10:00
Technology's Role in Addressing Global Threats|Carey Smith, CEO, Parsons Corporation.
00:10:00
Siemens CEO Kaeser on Flender Spinoff, Succession, Diversity | Ken Zinger, CEO, CES Energy Solutions CorpCEU:TOR
00:10:00
The Accelerating Impact of Technology in Financial Services | Piyush Gupta , CEO, DBS Bank .
00:10:00
Best Practices for Writing and Reviewing State Regulatory Communications
00:10:00
Tesla's Hydrogen-Powered Revolution|Elon Musk,CEO,Tesla
00:10:00
The mission to digitise, democratise, and decarbonise supply chains|Shereen Zarkani,Managing Partner and Head of Maersk Growth,Maersk Growth
00:10:00
Innovative Volume Rendering Solutions by Singular Health: Transforming Medical Imaging | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Everest Wealth Management - Expert Financial Advisors on "Die Groot Ontbyt"
00:10:00
The Right Value and the Right Clients with Guest Jason Speciner | JASON SPECINER - DIRECTOR OF INVESTMENT AND TAX PLANNING, FOUNDER
00:10:00
Discuss the strategy and five-year plan for Oxford Metrics|Nick Bolton, CEO,oxford metrics plc